1. Balant, L., Dayer, P., Rudhardt, M., Allaz, A.-F., Fabre, J. Cefoperazone: Pharmacokinetics in humans with normal and impaired renal function and pharmacokinetics in rats. Clin. Ther. 3, Special issue (1980) 50–59.
2. Lode, H., Kemmerich, B., Koeppe, P., Belmega, D., Jendroschek, H. Comparative pharmacokinetics of cefoperazone and cefotaxime. Clin. Ther. 3, Special issue (1980) 80–88.
3. Dayer, P., Balant, L., Rudhardt, M., Allaz, A.-F., Fabre, J. Behavior of cefoperazone (a new cephalosporin) in man: Influence of renal insufficiency. Kidney Int. 17 (1980) 857.
4. Fabre, J., Allaz, A.-F., Rudhardt, M., Dayer, P., Balant, L.: Pharmacokinetics of the cephalosporin T-1551 (cefoperazone) in normal men and in men with renal failure, and behavior in tissues of rats. Current Chemotherapy and Infectious Disease Proceedings of the 11th ICC and the 19th ICAAC American Society of Microbiology 1980.
5. Allaz, A.-F., Dayer, P., Fabre, L., Rudhardt, M., Balant, L. Pharmacocinétique d'une nouvelle céphalosporine, la céfopérazone. Schweiz. Med. Wochenschr. 109 (1979) 1999–2005.